Kauser Cardiac & Medical Centre

Kauser Cardiac & Medical Centre Latest state of the art and evidence based clinical management of diabetes, high blood pressure and

Our aim is to promote knowledge among the masses about cardiovascular diseases and diabetes and treat these disorders by explaining the benefits of early identification, counselling and latest tools.

12/12/2024

Management of diabetes.Clues towards correct diabetes treatment.Tips n tricks in diabetes managementDepression

08/04/2018

This site is intended for healthcare professionals
Edition: ENGLISH DEUTSCH ESPAÑOL FRANÇAIS PORTUGUÊS
Invitations 0 Dr. R Siddiqi

The Anti-statin Lobby Strikes Again: Time to Set the Record Straight:

The joint Franco-German non-commercial television network ARTE recently broadcast a television programme entitled 'The Big Bluff' about the link between cholesterol, cardiovascular disease, and the use of statins. The programme propounded the theory that there is absolutely no relation between blood cholesterol levels and cardiovascular disease, and asserted that cholesterol has become the 'ideal villain' in cardiovascular disease through a series of 'scientific approximations'. In addition, the programme encouraged physicians and patients to interrupt lipid-lowering treatments and statins, in particular, to avoid any blood lipid assessment and last but not least, suggested that the recommendations issued by professional societies such as the European Society of Cardiology (ESC) are inappropriate and influenced by conflicts of interest.

This position is astounding and shocking because it is in total opposition to the current state of scientific knowledge regarding the low-density lipoprotein (LDL)—statin—cardiovascular disease triad. It is now established that there is not only a link between LDL cholesterol and cardiovascular disease but in fact that LDL cholesterol is a proven causal factor of atherosclerosis.[1] Secondly, an analysis of almost 25 000 patients found that a reduction of 1 mmol/L in LDL cholesterol was associated with a 20% reduction in major vascular events {rate ratio 0.79 [95% confidence interval (CI) 0.77 − 0.81]}. Statin therapy is associated with a significant benefit in terms of LDL reduction, major vascular events and overall mortality.[2] Indeed, there is a linear relationship between the reduction in LDL cholesterol and the reduction in cardiovascular events, and this relation persists and is safe even at extremely low values of LDL (below currently recommended targets).[3]

Clearly, in the face of overwhelming scientific evidence, the disinformation campaign launched by ARTE must be unanimously denounced. This is not the first time that negative news stories have circulated about the alleged inefficacy or danger of statins, and the potential consequences on public opinion are immense. Firstly, there are definite negative repercussions for the doctor–patient relationship, which relies on a basis of trust. Clearly, alleging that patients are being prescribed inefficacious medications hand-over-fist by their doctors is not likely to enhance the trust patients accord to the medical profession.

Secondly, the impact on prevention treatments is major, because it may prompt untold legions of patients to discontinue their treatment without medical advice. This can lead to major clinical consequences, not least of which is death, myocardial infarction and stroke. Nielsen and Nordestgaard investigated the consequences of negative news stories on statin therapy continuation in 674 900 Danish individuals aged 40 or older who were initiated on statin therapy in the period 1995–2010 and who were followed up until the end of 2011.[4] They reported that negative statin-related news stories were associated with a significant increase in statin discontinuation {odds ratio 1.09 [95% confidence interval (CI) 1.06–1.12]}, and among those who discontinued statins, the hazard ratios for myocardial infarction, and death from cardiovascular disease increased [1.26 (95% CI 1.21–1.30) and 1.18 (95% CI 1.14–1.23), respectively]

Early statin discontinuation vs. continued use and cumulative incidence of myocardial infarction (top panel) and death from cardiovascular disease (bottom panel). Reproduced with permission from Nielsen SF, et al. Eur Heart J 2016;37 (11):908–916. 10.1093/eurheartj/ehv641.

A similar controversy previously arose in France after a retired professor of medicine published a book denying the benefits of statins on cardiovascular disease. In 2013, an investigation of the impact of this controversy on the use of statins among regular users found that discontinuation rates after this negative media coverage were significantly higher than before it, involving patients at low, but also at very high cardiovascular risk.[6]

When disinformation on major cardiovascular health issues abounds, the ESC, in particular through its Media Committee, has an important role to play as a source of reliable and balanced information. In addition to the regular publication and update of recommendations for the prevention and management of cardiovascular diseases, the ESC should be a driving force in disseminating scientifically founded information. It must act as a privileged partner for both the public and the press to inform them about matters pertaining to cardiovascular disease.

Immediately following the television programme, the ESC swiftly published a press release criticizing the content of the broadcast,[7] underlining the need to counteract the potentially harmful effects of statin naysayers. It's time to set the record straight because the repercussions for the misinformed are potentially catastrophic.

06/02/2018

Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes
Jennifer Abbasi
Article Information
JAMA. 2018;319(3):215-217. doi:10.1001/jama.2017.20639
related articles icon Related
Articles
This summer, 25 overweight and obese adults participating in a tightly controlled feeding study will take up full-time residence for 3 months at a wooded lakefront center in Ashland, Massachusetts. However, before checking in at Framingham State University’s Warren Conference Center and Inn, they will have to lose 15% of their body weight on a calorie-restricted diet with home-delivered meals.

Image description not available.
Those who pass this hurdle will be invited to the inn, where they’ll be randomly assigned to 1 of 3 equal-calorie diets: a low-fat, high-carbohydrate diet that’s either high or low in added sugar or a very low-carbohydrate, high-fat ketogenic diet that causes the body to switch from burning carbohydrates to burning fat.

The group will be the first of 5 that will participate in the trial over 3 years. Changes in body fat mass and energy expenditure will be assessed to determine if any of the diets have a unique effect on metabolism, while controlling calorie intake, in people who have already lost weight.

“It’s hard to lose weight, but it’s much harder to maintain that weight loss because of well-described physiological adaptations,” said coprincipal investigator David S. Ludwig, MD, PhD, a professor of pediatrics and nutrition at Harvard Medical School and Harvard T.H. Chan School of Public Health. After most diet-induced weight loss, “hunger goes up and metabolic rate goes down, and tendency to restore fat increases.”

But there are hints that the ketogenic diet may be different. A meta-analysis of 13 randomized controlled trials suggested that people on ketogenic diets tend to lose more weight and keep more of it off than people on low-fat diets. People placed on these diets often report decreased hunger, according to Amy Miskimon Goss, PhD, RD, an assistant professor at the University of Alabama at Birmingham (UAB) Nutrition Obesity Research Center. The appetite-suppressing powers of the diet aren’t fully understood but could have to do with the satiating properties of fat and protein, changes in appetite-regulating hormones on a low-carb diet, a direct hunger-reducing role of ketone bodies—the body’s main fuel source on the diet—or other factors.

Additionally, the ketogenic diet may not affect metabolism the same way other diets do. In a previous study, Ludwig found that metabolism slowed by more than 400 kcal/d on a low-fat diet while there was no significant decline in metabolic rate on a very low-carb diet.

“The quality of calories consumed may affect the number of calories burned,” he said. “If this apparent metabolic benefit persists, it could play an important role in improving the success of long-term weight-loss maintenance.”

Weight Loss on a High-Fat Diet
Despite decades of dietary guidelines promoting low-fat eating, around 40% of US adults and 19% of US children are now obese. What’s worse, more than half of today’s children are expected to be obese by age 35 years, according to recent modeling at Harvard.

With the runaway train of obesity and the growing recognition of the role of sugar and other high glycemic index carbohydrates in metabolic syndrome, some researchers and clinicians are shifting their attention to a very low-carb ketogenic approach like the one Ludwig and his collaborators at Framingham State University, UAB, and Indiana University are testing.

Carbohydrates comprise around 55% of the typical American diet, ranging from 200 to 350 g/d depending on a person’s overall caloric intake. Clinical ketogenic diets restrict daily carbs to somewhere between 20 g and 50 g, primarily from nonstarchy vegetables.

Deprived of dietary sugars and starches on the very low-carb diet, the body reduces insulin secretion and switches to primarily burning fat within a week. In this metabolic state—called nutritional ketosis—the liver converts fatty acids into compounds called ketone bodies that can pe*****te the blood-brain barrier and provide fuel to the brain, as well as the body’s other tissues.

Previous low-carb diets, like the original Atkins diet, emphasized protein and limited fat. But amino acids in protein can be converted to glucose, kicking the body out of ketosis. Therefore, a well-formulated ketogenic diet limits protein to adequate amounts to maintain lean body mass but doesn’t restrict fat or overall calories.

Despite being allowed to eat fat to satiety, people on a ketogenic diet often experience rapid weight loss—up to 10 pounds in 2 weeks, noted Goss, who researches the diet and uses it to treat obesity and type 2 diabetes at UAB. The diet has a diuretic effect, and some of those initial pounds are water weight. But as insulin levels decline and the body switches to fat-burning mode, it draws on fat depots, leading to further reductions in weight, Goss said.

Meanwhile, because many people feel less hungry on a ketogenic diet, they often naturally reduce their overall caloric intake, which could aid in their weight loss, said Bruce Bistrian, MD, PhD, a professor of medicine at Harvard Medical School and chief of clinical nutrition at Beth Israel Deaconess Medical Center in Boston. Just how much they may lose depends on many factors, including the amount of calories they spontaneously reduce, as well as their starting total fat and lean mass, age, s*x, ethnicity, and activity level, he said.

In a recent 8-week randomized trial including 34 obese men and women 60 through 75 years old, those who ate a ketogenic diet lost 9.7% of their body fat, while those on a low-fat diet lost just 2.1%. The ketogenic dieters also lost 3 times more visceral adipose tissue than the low-fat dieters, according to Goss, who presented the data at last year’s meeting of The Obesity Society.

Beyond Weight Loss
There’s also increasing interest in the ketogenic diet for diabetes management. Insulin sensitivity improves on the diet—although the mechanisms are not entirely clear—along with glycemic control.

“It seems to help people not only lose weight but reduce their requirement for [diabetes] medications, and they get improvements in their hemoglobin A1c [HbA1c], which is an end point for diabetes management,” said Steven Heymsfield, MD, a professor in the department of metabolism and body composition at Louisiana State University’s Pennington Biomedical Research Center and president-elect of The Obesity Society. “Those are all the good things that happen over the relatively short-term—6 months perhaps to a year. I think that the question is, is this a diet you can tolerate long-term?”

Stephen Phinney, MD, PhD, an emeritus professor of medicine at the University of California, Davis, is investigating just that. In 2015, he launched a telemedicine-based type 2 diabetes clinic called Virta Health. Virta’s physicians and dieticians coach patients on safely using a ketogenic diet to treat their condition.

The 10-week results of an ongoing 5-year Virta Health study demonstrated HbA1c-level improvements (an increase from 19.8% to 56.1% of participants with levels lower than 6.5%), diabetes medication reductions and eliminations (56.8% of participants), and body mass decreases (7.2% on average). Of the 262 patients who enrolled in the study, 238 stayed in the program for at least 10 weeks. In 6-month data, the average weight loss from baseline was 12%, with an 89% retention rate. Phinney plans to publish 1-year data soon.

Beyond helping people reduce their weight and get control of their blood glucose, ketogenic diets may also be heart-healthy, thanks to improvements in triglycerides, high-density lipoprotein (HDL) cholesterol levels, abdominal circumference, and blood pressure.

Low-density lipoprotein (LDL) cholesterol levels increase for some on the diet. Emphasizing unsaturated rather than saturated fat could help ward off these increases, but experts disagree on the ideal fat composition of the diet. An important caveat is that there appears to be a shift from more harmful small, dense LDL particles to less-harmful large, nondense particles on the diet.

Rick Hecht, MD, is research director of the Osher Center for Integrative Medicine at the University of California, San Francisco, where he studies nonpharmacological approaches to chronic disease. He said more data are needed on long-term outcomes of the LDL level increases resulting from a ketogenic diet. But, he adds, “For people with type 2 diabetes, I think the risks of poor glycemic control from excessive carbohydrate intake far outweigh the risks of saturated fats, and most people with type 2 diabetes should focus on limiting carbohydrates—particularly simple carbohydrates—as a greater priority than saturated fat.”

A diet that lets a person eat fat to satiety—even saturated fat—without relying on calorie counting and still lose substantial weight, treat diabetes into remission, raise HDL levels, and lower triglycerides and blood pressure? It could be game changing for the field of chronic disease—if the benefits pan out in large-scale trials and can be sustained by many.

“Anecdotally, individuals have lost hundreds of pounds on the ketogenic diet and kept it off long-term by adopting the diet as a permanent diet change,” Goss said. “Our lab suspects it works particularly well in individuals with an underlying metabolic phenotype characterized by relatively high insulin secretion.”

Eric Westman, MD, an associate professor of medicine at Duke University School of Medicine, has been using the ketogenic diet as the first-line therapy for obesity and type 2 diabetes at the Duke Lifestyle Medicine Clinic for a decade. Like Goss, Westman has seen many patients stick to the diet long enough to lose 100 or more pounds, which can take over a year. For him, the ketogenic diet is a food-based treatment alternative to weight-loss drugs and bariatric surgery.

He said the very low-carb diet can be a challenge, especially for patients with a strong sweet tooth. But about a third of his patients find it surprisingly easy to make the switch.

Safe, With Caveats
In addition to being the standard fare for populations at northern latitudes that historically had very few, if any, plant products for most of the year, ketogenic diets have been used without adverse effects over the past century to treat drug-resistant epilepsy in children.

“Generally speaking, it’s safe,” Heymsfield said.

The most common adverse effects of the diet, collectively referred to as the “keto flu,” include lightheadedness, dizziness, fatigue, difficulty exercising, poor sleep, and constipation, which tend to pass in a few days to a few weeks. Getting protein from whole foods rather than purified protein products helps ensure adequate intake of sodium, potassium, and magnesium on the diet, which can help counter some of these effects.

That said, for both safety and efficacy reasons, “this is not a do-it-yourself diet,” according to Bistrian. People taking insulin or oral hypoglycemic medications for diabetes can experience serious hypoglycemia on the ketogenic diet and should therefore consult with an experienced clinician to safely adjust medications when initiating it. Blood pressure medications may also need to be adjusted. Bistrian also emphasized that “continued participation with an organized program with monitoring is much more likely to lead to long-term good results.”

Hecht is also cautious about people doing the ketogenic diet on their own for weight loss, particularly if they have diabetes. In addition to the medication considerations, he said most patients need significant training to follow the diet. Additionally, although some people—especially those with insulin resistance—need to drastically cut carbs to lose weight and improve glucose levels, others can get good results from a Mediterranean diet.

“I don’t think everyone should be carbohydrate restricting to the level of a ketogenic diet just because they want to lose weight,” Hecht said. “We need to understand better the predictors of who’s going to benefit from this diet.”

The carbohydrate restrictions may not need to be life-long. Once a goal weight is reached, some people may be able to add back a limited amount of carbs, cut back a bit on fat, and still keep their weight down, Phinney and others said. The amount of daily carbs a person on a maintenance diet can eat before their weight starts to creep back up will depend on their individual carb tolerance.

People with type 2 diabetes, on the other hand, may need to stay on the diet to control their disease.

For now, Ludwig said the evidence for very low-carb-diets for weight loss and diabetes management is still preliminary, but funding for high-quality research could change that. His weight-maintenance study is funded by a $12 million philanthropic grant from the Laura and John Arnold Foundation.

“We know from epidemiology and public health that the majority of chronic disease in this country is lifestyle-related, and primarily nutrition-related,” he said. “It should be among our highest scientific priorities to invest in top-quality, long-term, rigorous nutrition research, so we can answer questions that have befuddled us for a century or more regarding low-fat versus low-carb diets.”

06/02/2018

Vitamin and Mineral Supplements
What Clinicians Need to Know
Dietary supplementation is approximately a $30 billion industry in the United States, with more than 90 000 products on the market. In recent national surveys, 52% of US adults reported use of at least 1 supplement product, and 10% reported use of at least 4 such products. Vitamins and minerals are among the most popular supplements and are taken by 48% and 39% of adults, respectively, typically to maintain health and prevent disease.

Despite this enthusiasm, most randomized clinical trials of vitamin and mineral supplements have not demonstrated clear benefits for primary or secondary prevention of chronic diseases not related to nutritional deficiency. Indeed, some trials suggest that micronutrient supplementation in amounts that exceed the recommended dietary allowance (RDA)—eg, high doses of beta carotene, folic acid, vitamin E, or selenium—may have harmful effects, including increased mortality, cancer, and hemorrhagic stroke.

In this Viewpoint, we provide information to help clinicians address frequently asked questions about micronutrient supplements from patients, as well as promote appropriate use and curb inappropriate use of such supplements among generally healthy individuals. Importantly, clinicians should counsel their patients that such supplementation is not a substitute for a healthful and balanced diet and, in most cases, provides little if any benefit beyond that conferred by such a diet.

Clinicians should also highlight the many advantages of obtaining vitamins and minerals from food instead of from supplements. Micronutrients in food are typically better absorbed by the body and are associated with fewer potential adverse effects. A healthful diet provides an array of nutritionally important substances in biologically optimal ratios as opposed to isolated compounds in highly concentrated form. Indeed, research shows that positive health outcomes are more strongly related to dietary patterns and specific food types than to individual micronutrient or nutrient intakes.

Although routine micronutrient supplementation is not recommended for the general population, targeted supplementation may be warranted in high-risk groups for whom nutritional requirements may not be met through diet alone, including people at certain life stages and those with specific risk factors.

Box.
Key Points on Vitamin and Mineral Supplements
General Guidance for Supplementation in a Healthy Population by Life Stage
Pregnancy: folic acid, prenatal vitamins

Infants and children: for breastfed infants, vitamin D until weaning and iron from age 4-6 mo

Midlife and older adults: some may benefit from supplemental vitamin B12, vitamin D, and/or calcium

Guidance for Supplementation in High-Risk Subgroups
Medical conditions that interfere with nutrient absorption or metabolism:

Bariatric surgery: fat-soluble vitamins, B vitamins, iron, calcium, zinc, copper, multivitamins/multiminerals

Pernicious anemia: vitamin B12 (1-2 mg/d orally or 0.1-1 mg/mo intramuscularly)

Crohn disease, other inflammatory bowel disease, celiac disease: iron, B vitamins, vitamin D, zinc, magnesium

Osteoporosis or other bone health issues: vitamin D, calcium, magnesiuma

Age-related macular degeneration: specific formulation of antioxidant vitamins, zinc, copper

Medications (long-term use):

Proton pump inhibitorsa: vitamin B12, calcium, magnesium

Metformina: vitamin B12

Restricted or suboptimal eating patterns: multivitamins/multiminerals, vitamin B12, calcium, vitamin D, magnesium

a Inconsistent evidence.

Pregnancy
The evidence is clear that women who may become pregnant or who are in the first trimester of pregnancy should be advised to consume adequate folic acid (0.4-0.8 mg/d) to prevent neural tube defects. Folic acid is one of the few micronutrients more bioavailable in synthetic form from supplements or fortified foods than in the naturally occurring dietary form (folate). Prenatal multivitamin/multimineral supplements will provide folic acid as well as vitamin D and many other essential micronutrients during pregnancy. Pregnant women should also be advised to eat an iron-rich diet. Although it may also be prudent to prescribe supplemental iron for pregnant women with low levels of hemoglobin or ferritin to prevent and treat iron-deficiency anemia, the benefit-risk balance of screening for anemia and routine iron supplementation during pregnancy is not well characterized.

Supplemental calcium may reduce the risk of gestational hypertension and preeclampsia, but confirmatory large trials are needed. Use of high-dose vitamin D supplements during pregnancy also warrants further study. The American College of Obstetricians and Gynecologists has developed a useful patient handout on micronutrient nutrition during pregnancy.

Infants and Children
The American Academy of Pediatrics recommends that exclusively or partially breastfed infants receive (1) supplemental vitamin D (400 IU/d) starting soon after birth and continuing until weaning to vitamin D–fortified whole milk (≥1 L/d) and (2) supplemental iron (1 mg/kg/d) from 4 months until the introduction of iron-containing foods, usually at 6 months. Infants who receive formula, which is fortified with vitamin D and (often) iron, do not typically require additional supplementation. All children should be screened at 1 year for iron deficiency and iron-deficiency anemia.

Healthy children consuming a well-balanced diet do not need multivitamin/multimineral supplements, and they should avoid those containing micronutrient doses that exceed the RDA. In recent years, ω-3 fatty acid supplementation has been viewed as a potential strategy for reducing the risk of autism spectrum disorder or attention-deficit/hyperactivity disorder in children, but evidence from large randomized trials is lacking.

Midlife and Older Adults
With respect to vitamin B12, adults aged 50 years and older may not adequately absorb the naturally occurring, protein-bound form of this nutrient and thus should be advised to meet the RDA (2.4 μg/d) with synthetic B12 found in fortified foods or supplements.6 Patients with pernicious anemia will require higher doses (Box).

Regarding vitamin D, currently recommended intakes (from food or supplements) to maintain bone health are 600 IU/d for adults up to age 70 years and 800 IU/d for those aged older than 70 years. Some professional organizations recommend 1000 to 2000 IU/d, but it has been widely debated whether doses above the RDA offer additional benefits. Ongoing large-scale randomized trials (NCT01169259 and ACTRN12613000743763) should help to resolve continuing uncertainties soon.

With respect to calcium, current RDAs are 1000 mg/d for men aged 51 to 70 years and 1200 mg/d for women aged 51 to 70 years and for all adults aged older than 70 years. Given recent concerns that calcium supplements may increase the risk for kidney stones and possibly cardiovascular disease, patients should aim to meet this recommendation primarily by eating a calcium-rich diet and take calcium supplements only if needed to reach the RDA goal (often only about 500 mg/d in supplements is required). A recent meta-analysis suggested that supplementation with moderate-dose calcium (

01/02/2018

FINDRISC is a prediction tool to identify patients at risk of developing diabetes.

It requires no laboratory testing and has been validated in multiple populations. FINDRISC uses age, BMI, physical activity, vegetable & fruit intake, medical treatment of hypertension, history of hyperglycemia and family history to determine risk of developing diabetes.

By using FINDRISC to identify high-risk people and applying an educational intervention, it has been shown possible to reduce the incidence of diabetes.

Estimate risk of developing diabetes and frequency of screening required.

01/02/2018

Parsing the difference between a cold and flu isn't so easy. WebMD's slideshow explains how to tell the difference - and how to treat your symptoms.

30/01/2018

January 16, 2018
Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes
Jennifer Abbasi
This summer, 25 overweight and obese adults participating in a tightly controlled feeding study will take up full-time residence for 3 months at a wooded lakefront center in Ashland, Massachusetts. However, before checking in at Framingham State University’s Warren Conference Center and Inn, they will have to lose 15% of their body weight on a calorie-restricted diet with home-delivered meals.

Those who pass this hurdle will be invited to the inn, where they’ll be randomly assigned to 1 of 3 equal-calorie diets: a low-fat, high-carbohydrate diet that’s either high or low in added sugar or a very low-carbohydrate, high-fat ketogenic diet that causes the body to switch from burning carbohydrates to burning fat.
The group will be the first of 5 that will participate in the trial over 3 years. Changes in body fat mass and energy expenditure will be assessed to determine if any of the diets have a unique effect on metabolism, while controlling calorie intake, in people who have already lost weight.
“It’s hard to lose weight, but it’s much harder to maintain that weight loss because of well-described physiological adaptations,” said coprincipal investigator David S. Ludwig, MD, PhD, a professor of pediatrics and nutrition at Harvard Medical School and Harvard T.H. Chan School of Public Health. After most diet-induced weight loss, “hunger goes up and metabolic rate goes down, and tendency to restore fat increases.”
But there are hints that the ketogenic diet may be different. A meta-analysis of 13 randomized controlled trials suggested that people on ketogenic diets tend to lose more weight and keep more of it off than people on low-fat diets. People placed on these diets often report decreased hunger, according to Amy Miskimon Goss, PhD, RD, an assistant professor at the University of Alabama at Birmingham (UAB) Nutrition Obesity Research Center. The appetite-suppressing powers of the diet aren’t fully understood but could have to do with the satiating properties of fat and protein, changes in appetite-regulating hormones on a low-carb diet, a direct hunger-reducing role of ketone bodies—the body’s main fuel source on the diet—or other factors.
Additionally, the ketogenic diet may not affect metabolism the same way other diets do. In a previous study, Ludwig found that metabolism slowed by more than 400 kcal/d on a low-fat diet while there was no significant decline in metabolic rate on a very low-carb diet.
“The quality of calories consumed may affect the number of calories burned,” he said. “If this apparent metabolic benefit persists, it could play an important role in improving the success of long-term weight-loss maintenance.”
Weight Loss on a High-Fat Diet
Despite decades of dietary guidelines promoting low-fat eating, around 40% of US adults and 19% of US children are now obese. What’s worse, more than half of today’s children are expected to be obese by age 35 years, according to recent modeling at Harvard.
With the runaway train of obesity and the growing recognition of the role of sugar and other high glycemic index carbohydrates in metabolic syndrome, some researchers and clinicians are shifting their attention to a very low-carb ketogenic approach like the one Ludwig and his collaborators at Framingham State University, UAB, and Indiana University are testing.
Carbohydrates comprise around 55% of the typical American diet, ranging from 200 to 350 g/d depending on a person’s overall caloric intake. Clinical ketogenic diets restrict daily carbs to somewhere between 20 g and 50 g, primarily from nonstarchy vegetables.
Deprived of dietary sugars and starches on the very low-carb diet, the body reduces insulin secretion and switches to primarily burning fat within a week. In this metabolic state—called nutritional ketosis—the liver converts fatty acids into compounds called ketone bodies that can pe*****te the blood-brain barrier and provide fuel to the brain, as well as the body’s other tissues.
Previous low-carb diets, like the original Atkins diet, emphasized protein and limited fat. But amino acids in protein can be converted to glucose, kicking the body out of ketosis. Therefore, a well-formulated ketogenic diet limits protein to adequate amounts to maintain lean body mass but doesn’t restrict fat or overall calories.
Despite being allowed to eat fat to satiety, people on a ketogenic diet often experience rapid weight loss—up to 10 pounds in 2 weeks, noted Goss, who researches the diet and uses it to treat obesity and type 2 diabetes at UAB. The diet has a diuretic effect, and some of those initial pounds are water weight. But as insulin levels decline and the body switches to fat-burning mode, it draws on fat depots, leading to further reductions in weight, Goss said.
Meanwhile, because many people feel less hungry on a ketogenic diet, they often naturally reduce their overall caloric intake, which could aid in their weight loss, said Bruce Bistrian, MD, PhD, a professor of medicine at Harvard Medical School and chief of clinical nutrition at Beth Israel Deaconess Medical Center in Boston. Just how much they may lose depends on many factors, including the amount of calories they spontaneously reduce, as well as their starting total fat and lean mass, age, s*x, ethnicity, and activity level, he said.
In a recent 8-week randomized trial including 34 obese men and women 60 through 75 years old, those who ate a ketogenic diet lost 9.7% of their body fat, while those on a low-fat diet lost just 2.1%. The ketogenic dieters also lost 3 times more visceral adipose tissue than the low-fat dieters, according to Goss, who presented the data at last year’s meeting of The Obesity Society.
Beyond Weight Loss
There’s also increasing interest in the ketogenic diet for diabetes management. Insulin sensitivity improves on the diet—although the mechanisms are not entirely clear—along with glycemic control.
“It seems to help people not only lose weight but reduce their requirement for [diabetes] medications, and they get improvements in their hemoglobin A1c [HbA1c], which is an end point for diabetes management,” said Steven Heymsfield, MD, a professor in the department of metabolism and body composition at Louisiana State University’s Pennington Biomedical Research Center and president-elect of The Obesity Society. “Those are all the good things that happen over the relatively short-term—6 months perhaps to a year. I think that the question is, is this a diet you can tolerate long-term?”
Stephen Phinney, MD, PhD, an emeritus professor of medicine at the University of California, Davis, is investigating just that. In 2015, he launched a telemedicine-based type 2 diabetes clinic called Virta Health. Virta’s physicians and dieticians coach patients on safely using a ketogenic diet to treat their condition.
The 10-week results of an ongoing 5-year Virta Health study demonstrated HbA1c-level improvements (an increase from 19.8% to 56.1% of participants with levels lower than 6.5%), diabetes medication reductions and eliminations (56.8% of participants), and body mass decreases (7.2% on average). Of the 262 patients who enrolled in the study, 238 stayed in the program for at least 10 weeks. In 6-month data, the average weight loss from baseline was 12%, with an 89% retention rate. Phinney plans to publish 1-year data soon.
Beyond helping people reduce their weight and get control of their blood glucose, ketogenic diets may also be heart-healthy, thanks to improvements in triglycerides, high-density lipoprotein (HDL) cholesterol levels, abdominal circumference, and blood pressure.
Low-density lipoprotein (LDL) cholesterol levels increase for some on the diet. Emphasizing unsaturated rather than saturated fat could help ward off these increases, but experts disagree on the ideal fat composition of the diet. An important caveat is that there appears to be a shift from more harmful small, dense LDL particles to less-harmful large, nondense particles on the diet.
Rick Hecht, MD, is research director of the Osher Center for Integrative Medicine at the University of California, San Francisco, where he studies nonpharmacological approaches to chronic disease. He said more data are needed on long-term outcomes of the LDL level increases resulting from a ketogenic diet. But, he adds, “For people with type 2 diabetes, I think the risks of poor glycemic control from excessive carbohydrate intake far outweigh the risks of saturated fats, and most people with type 2 diabetes should focus on limiting carbohydrates—particularly simple carbohydrates—as a greater priority than saturated fat.”
A diet that lets a person eat fat to satiety—even saturated fat—without relying on calorie counting and still lose substantial weight, treat diabetes into remission, raise HDL levels, and lower triglycerides and blood pressure? It could be game changing for the field of chronic disease—if the benefits pan out in large-scale trials and can be sustained by many.
“Anecdotally, individuals have lost hundreds of pounds on the ketogenic diet and kept it off long-term by adopting the diet as a permanent diet change,” Goss said. “Our lab suspects it works particularly well in individuals with an underlying metabolic phenotype characterized by relatively high insulin secretion.”
Eric Westman, MD, an associate professor of medicine at Duke University School of Medicine, has been using the ketogenic diet as the first-line therapy for obesity and type 2 diabetes at the Duke Lifestyle Medicine Clinic for a decade. Like Goss, Westman has seen many patients stick to the diet long enough to lose 100 or more pounds, which can take over a year. For him, the ketogenic diet is a food-based treatment alternative to weight-loss drugs and bariatric surgery.
He said the very low-carb diet can be a challenge, especially for patients with a strong sweet tooth. But about a third of his patients find it surprisingly easy to make the switch.
Safe, With Caveats
In addition to being the standard fare for populations at northern latitudes that historically had very few, if any, plant products for most of the year, ketogenic diets have been used without adverse effects over the past century to treat drug-resistant epilepsy in children.
“Generally speaking, it’s safe,” Heymsfield said.
The most common adverse effects of the diet, collectively referred to as the “keto flu,” include lightheadedness, dizziness, fatigue, difficulty exercising, poor sleep, and constipation, which tend to pass in a few days to a few weeks. Getting protein from whole foods rather than purified protein products helps ensure adequate intake of sodium, potassium, and magnesium on the diet, which can help counter some of these effects.
That said, for both safety and efficacy reasons, “this is not a do-it-yourself diet,” according to Bistrian. People taking insulin or oral hypoglycemic medications for diabetes can experience serious hypoglycemia on the ketogenic diet and should therefore consult with an experienced clinician to safely adjust medications when initiating it. Blood pressure medications may also need to be adjusted. Bistrian also emphasized that “continued participation with an organized program with monitoring is much more likely to lead to long-term good results.”
Hecht is also cautious about people doing the ketogenic diet on their own for weight loss, particularly if they have diabetes. In addition to the medication considerations, he said most patients need significant training to follow the diet. Additionally, although some people—especially those with insulin resistance—need to drastically cut carbs to lose weight and improve glucose levels, others can get good results from a Mediterranean diet.
“I don’t think everyone should be carbohydrate restricting to the level of a ketogenic diet just because they want to lose weight,” Hecht said. “We need to understand better the predictors of who’s going to benefit from this diet.”
The carbohydrate restrictions may not need to be life-long. Once a goal weight is reached, some people may be able to add back a limited amount of carbs, cut back a bit on fat, and still keep their weight down, Phinney and others said. The amount of daily carbs a person on a maintenance diet can eat before their weight starts to creep back up will depend on their individual carb tolerance.
People with type 2 diabetes, on the other hand, may need to stay on the diet to control their disease.
For now, Ludwig said the evidence for very low-carb-diets for weight loss and diabetes management is still preliminary, but funding for high-quality research could change that. His weight-maintenance study is funded by a $12 million philanthropic grant from the Laura and John Arnold Foundation.
“We know from epidemiology and public health that the majority of chronic disease in this country is lifestyle-related, and primarily nutrition-related,” he said. “It should be among our highest scientific priorities to invest in top-quality, long-term, rigorous nutrition research, so we can answer questions that have befuddled us for a century or more regarding low-fat versus low-carb diets.”

Address

Nadeem Pride, Block: 13-D/2, Gulshan Iqbal, Near Aga Khan Collection Point
Karachi

Alerts

Be the first to know and let us send you an email when Kauser Cardiac & Medical Centre posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Kauser Cardiac & Medical Centre:

Share